Targeting Intercellular Communication with Nanomedicine and Advanced Therapeutics delves into the complex world of intercellular communication biology and its implications on therapeutics. This book covers all areas of intercellular communication and therapeutics in development for different forms of communication, including their role in diseases such as cancer, neurological disorders, metabolic diseases, and inflammatory/immune diseases. Sections provide an introduction, biological targets, challenges, and approaches to overcoming biological barriers and the significance of contact points and mechanisms of internalization. Specifics of tunneling nanotubes, extracellular vesicles, and the immune and non-immune interface in various diseases are covered. Furthermore, the book explores the crosstalk of different forms of intercellular communication and the implications of mitochondrial exchange in the four primary pathological areas. This is an essential resource for researchers, students, and professionals in the field of drug development and delivery. By connecting the dots between extracellular vesicles, tunneling nanotubes, and cell-cell junctions, this book serves as a foundation for further advancements in the science of intercellular communication and it's applications to new drug discovery and delivery. Provides a comprehensive analysis of intercellular communication biology and its connection to various diseases - Includes comprehensive discussions on tunneling nanotubes, extracellular vesicles, and cell-cell junctions for therapeutic development - Explores immune and non-immune interfaces in cancer, neurological, metabolic, and inflammatory/immune diseases for well-rounded knowledge - Presents an overview of the crosstalk of different forms of intercellular communication for enhanced research - Examines the implications of mitochondrial exchange in pathological areas, paving the way for cutting-edge discoveries Provides a comprehensive guide to the biology, interplay, and therapeutic manipulation of extracellular vesicles and tunneling nanotubes in the development of new drugs to fight cancer, neurological disorders, metabolic diseases, and inflammatory/immune diseases Targeting Intercellular Communication with Nanomedicine and Advanced Therapeutics delves into the complex world of intercellular communication biology and its implications on therapeutics. Despite significant progress in this field, there has been a lack of comprehensive understanding of the connections between different forms of communication and their role in diseases such as cancer, neurological disorders, metabolic diseases, and inflammatory/immune diseases. This book bridges this gap by providing equal insight into all areas of intercellular communication and the therapeutics in development aimed at these different forms of communication. The book is organized into fourteen chapters, covering a wide range of topics, including an introduction to the field, biological targets, challenges and approaches to overcoming biological barriers, and the significance of contact points and mechanisms of internalization. It delves into the specifics of tunneling nanotubes, extracellular vesicles, and the immune and non-immune interface in various diseases. Furthermore, it explores the crosstalk of different forms of intercellular communication and the implications of mitochondrial exchange in each of the four primary pathological areas. Targeting Intercellular Communication with Nanomedicine and Advanced Therapeutics is an essential resource for researchers, students, and professionals in the field of drug development and delivery. By connecting the dots between extracellular vesicles, tunneling nanotubes, and cell-cell junctions, this book serves as a foundation for further advancements in the science of intercellular communication and it's applications to new drug discovery and delivery. Biologists will also benefit from the way this book connects intercellular communication processes with therapeutic pathways. Dr. Lara Milane is Assistant Teaching Professor in Biotechnology at the Bouvé College of Health Sciences at Northeastern University. She is interested in Mitochondrial Medicine. She is working on developing nanomedicines for a range of diseases (cancer, neurodegenerative disease, aging) that manipulate mitochondria for therapeutic outcomes. Dr. Milane was trained as a National Cancer Institute/ National Science Foundation Nanomedicine Fellow at Northeastern University, Boston, MA. Dr. Milane is an intuitive cancer biologist with research interests in developing translational nanomedicines that exploit the hallmarks of cancer. Mansoor M. Amiji is the Distinguished Professor and Chairman of the Department of Pharmaceutical Sciences at the Bouvé College of Health Sciences at Northeastern University. Dr. Amiji has edited a number of books and is a frequently published author. His research focuses on the synthesis of novel polymeric